Gregory Bauman

Highline Sciences

Highline Sciences is a specialized, full-service clinical CRO and consultancy optimized to the needs of small to mid-market biotech, focused on oncology. The Highline team brings decades of expertise from site-level, biotech, and CRO roles, all with the common goal of improving the product development experience for all stakeholders. Highline's goal is deep partnerships with limited clients to provide A-team support across development programs, globally, from Phase I to Phase III. Highline strives to remain agile and flexible in order to accommodate the nature of complex and adaptive oncology trial designs. Through our unique services model, we help our clients ask the right questions and find the answers they need to identify promising therapies and support moving them to market.